FDA Approves Glumetza
FDA Approves Glumetza for Type 2 Diabetes
Glumetza is a once-daily, extended-release formulation of metformin hydrochloride which may offer potential advantages such as less frequent dosing and fewer side effects. Glumetza is indicated for the treatment of Type 2 diabetes.Related Articles:
Depomed Receives FDA Approval for 1000 mg Strength Tablets of Glumetza - January 2, 2008
Depomed, Biovail Update Status of Glumetza NDA - April 13, 2005
Biovail, Depomed Receive Approvable Letter from FDA for Extended-Release Glumetza for Type II Diabetes - March 1, 2005
Biovail, Depomed Announce Glumetza NDA Accepted by FDA - June 24, 2004
FDA Drug Approvals Archive
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Oct | Dec






